期刊文献+

年轻三阴性乳腺癌患者戈舍瑞林用药依从性调查及分析 被引量:2

Investigation and analysis of goserelin medication compliance in triple-negative young breast cancer patients
原文传递
导出
摘要 目的了解年轻三阴性乳腺癌(triple negative breast cancer,TNBC)患者使用戈舍瑞林保护卵巢功能的现状。方法回顾性收集2015年1月至2017年12月重庆医科大学附属第一医院乳腺外科经病理确诊为TNBC且有保护卵巢功能意愿的患者共47例,计算患者的戈舍瑞林药物占有比,通过电话随访方式调查患者的用药情况。结果成功随访31例,中位年龄31岁,年龄范围为14~41岁。80.6%(25/31)的患者戈舍瑞林用药依从性好,19.4%(6/31)的患者依从性差。Fisher精确检验显示,文化程度、经济情况和医保类型对戈舍瑞林依从性有影响,差异有统计学意义(P<0.05)。结论医护人员应多关注文化程度较低、经济条件较差TNBC患者的戈舍瑞林用药情况,为患者提供科学的用药指导和个体化的健康教育,做好患者的全程管理,提高患者的用药依从性。 Objective To understand the current status of the use of goserelin for protection of ovarian function in young patients with triple-negative breast cancer.Methods Clinical data of 47 patients pathologically diagnosed as triple-negative breast cancer from Jan.2015 to Dec.2017 and with a willingness to protect ovarian function were collected and retrospectively analyzed.Patients’drug share was calculated,and drug use was investigated by telephone follow-up.Results 31 patients were successfully followed up,aged 14-40 years,with a median age of 31 years.80.6%(25/31)patients had a compliance and 19.4%(6/31)patients had poor compliance.Fisher’s exact test showed that the degree of education,economic situation and type of medical insurance had an impact on compliance,and the difference was statistically significant(P<0.05).Conclusion Medical staff should pay more attention to the use of drugs in patients with lower education level and poor economic conditions,provide them with scientific medication guidance and individualized health education,do a good job of patient management,and improve patient compliance.
作者 陈霞 罗凤 Chen Xia;Luo Feng(Department of Endocrinology and Breast Surgery,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
出处 《中华内分泌外科杂志》 CAS 2020年第2期128-132,共5页 Chinese Journal of Endocrine Surgery
基金 重庆市科学技术委员会社会民生科技创新专项资助项目(cstc2016shmszx130024)。
关键词 三阴性乳腺癌 年轻乳腺癌 戈舍瑞林 依从性 Triple negative Young patients with breast cancer Goserelin Compliance
  • 相关文献

参考文献9

二级参考文献116

  • 1吴世凯,宋三泰.第三代芳香化酶抑制剂临床应用的常见不良反应[J].中国药物警戒,2006,3(2):68-71. 被引量:14
  • 2中华人民共和国卫生部.中国卫生部卫生统计年鉴EB/OL].(2012-09-14)[2012-12-01].http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2010/index2010.html.
  • 3NCCN.National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology,Breast Cancer[EB/OL].(2012-09-14)[2012-12-01].http://www.nccn.org/professionals/physician_ gls/f _ guidelines.asp #breast.
  • 4Hershman D L,Shao T,Kushi L H,et al.Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer[J].Breast Cancer Res Treat,2011,126(2):529-537.
  • 5Liu H,Colin C E,Miller L G,et al.A comparison study of multiple measures of adherence to HIV protease inhi-bitors[J].Ann Intern Med,2001,134(10):968-977.
  • 6Darkow T,Henk H J,Thomas S K,et al.Treatment interruptions and non-adherence with imatinib and associated healthcare costs:a retrospective analysis among managed care patients with chronic myelogenous leukaemia[J].Pharmacoeconomics,2007,25 (6):481-496.
  • 7Noens L,van Lierde M A,De Bock R,et al.Prevalence,determinants,and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia:the ADAGIO study[J].Blood,2009,113(22):5401-5411.
  • 8Ziller V,Kalder M,Albert U S,et al.Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer[J].Ann Oncol,2009,20 (3):431-436.
  • 9Fink A K,Gurwitz J,Rakowski W,et al.Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer[J].J Clin Oncol,2004,22(16):3309-3315.
  • 10Osterberg L,Blaschke T.Adherence to medication[J].N Engl J Med,2005,353(5):487-497.

共引文献160

同被引文献15

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部